Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.043 | 0.9 |